EUVIMEDEUVIMED entdecken
Open Access

Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation

Onur Sahin iD, Yuri Mackeyev iD, Geraldine V Vijay iD, Soumyabrata Roy iD, Ashokkumar Meiyazhagan iD, Yasmin Zahra iD, Okan Tezcan, Valeria Gonzalez iD, Belal Abousaida iD, Holden R Wagner iD, Pearl Fernandes iD, Riaz Mowzoon-Mogharrabi iD und 12 weitere

Science Advances · 28.03.2025 · 11 (13)

DOI: 10.1126/sciadv.adr4008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 28.03.2025. Verfasst von Onur Sahin und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Nanoengineering, Rice University, Houston, TX 77005, USA. Hauptthemen laut MEDLINE: Yttrium, Photosensitizing Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inadequate light penetration in tissues restricts photodynamic therapy to treating only superficial tumors. To enable x-ray–excited photodynamic therapy (XPDT) that targets deep-seated tumors, we synthesized a nanoscintillator-photosensitizer complex containing 5% Eu-doped Y 2 O 3 fluorescing at 611 nanometers and decorated with SiO 2 containing the scintillation-coupled photosensitizer methylene blue and a polyethylene glycol coating [PEGylated Y 2 O 3 :Eu@SiO 2 -methylene blue (pYSM)]. When irradiated, pYSMs generate singlet oxygen species in vitro, causing cytotoxicity with hallmarks of immunogenic cell death (calreticulin translocation to the cell membrane). Intravenously administered pYSMs home passively to pancreatic tumor xenografts and, upon 10 gray irradiation, cause significant tumor regression ( P < 0.01). On combining XPDT with anti-PD1 immunotherapy, a distant nonirradiated tumor also regresses via an increase in intratumoral activated CD8 + cytotoxic T cells. Collectively, we advance a systemically delivered XPDT strategy that mediates an antitumor effect in both irradiated and nonirradiated (abscopal) tumors when coupled with immunotherapy, converting an immunologically “cold” tumor to an immunologically “hot” tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

YttriumPhotosensitizing AgentsAnimalsMiceX-RaysHumansPhotochemotherapyCell Line, TumorXenograft Model Antitumor AssaysSilicon DioxideMethylene Blue

Substanzen

YttriumPhotosensitizing AgentsyttriaSilicon DioxideMethylene Blue

Autor:innen und Institutionen

  • Department of Materials Science and Nanoengineering, Rice University, Houston, TX 77005, USA.
  • Department of Neurosurgery, McGovern Medical School at UTHealth Houston, Houston, TX 77030, USA.
  • Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224 USA.
  • Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
  • Department of Chemistry, University of California, Berkley, Berkley, CA 94720, USA.
  • Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15219, USA.

ORCID-Profile: Onur Sahin, Yuri Mackeyev, Geraldine V Vijay, Soumyabrata Roy, Ashokkumar Meiyazhagan, Yasmin Zahra, Valeria Gonzalez, Belal Abousaida, Holden R Wagner, Pearl Fernandes, Riaz Mowzoon-Mogharrabi, Cheng-En Hsieh, Xiang Zhang, Kristen A Miller, Guanhui Gao, Rao V L Papineni, Sunil Krishnan

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

Sahin, O., Mackeyev, Y., Vijay, G. V., Roy, S., Meiyazhagan, A., Zahra, Y., Tezcan, O., Gonzalez, V., Abousaida, B., Wagner, H. R., Fernandes, P., Mowzoon-Mogharrabi, R., Venkatesulu, B. P., Hsieh, C. E., Kim, J. B. K., Raghuram, S., Zhang, X., Miller, K. A., Gao, G., …, & Krishnan, S. (2025). Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation. Science Advances, 11(13). https://doi.org/10.1126/sciadv.adr4008

Vancouver

Sahin O, Mackeyev Y, Vijay GV, Roy S, Meiyazhagan A, Zahra Y, et al. Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation. Science Advances. 2025;11(13). doi:10.1126/sciadv.adr4008

BibTeX
@article{Sahin2025,
  author = {Sahin, Onur and Mackeyev, Yuri and Vijay, Geraldine V and Roy, Soumyabrata and Meiyazhagan, Ashokkumar and Zahra, Yasmin and Tezcan, Okan and Gonzalez, Valeria and Abousaida, Belal and Wagner, Holden R and Fernandes, Pearl and Mowzoon-Mogharrabi, Riaz and Venkatesulu, Bhanu P and Hsieh, Cheng-En and Kim, Joseph B K and Raghuram, Subhiksha and Zhang, Xiang and Miller, Kristen A and Gao, Guanhui and Singh, Pankaj K and Cho, Sang Hyun and Papineni, Rao V L and Ajayan, Pulickel M and Krishnan, Sunil},
  title = {Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {13},
  doi = {10.1126/sciadv.adr4008}
}
Kostenlos starten →